Abiopharma

New Form 4 - BOSTON SCIENTIFIC CORP Filed: 2025-08-04 AccNo: 0001225208-25-006986 Size: 9 KB

New Form 4 - BOSTON SCIENTIFIC CORP Filed: 2025-08-04 AccNo: 0001225208-25-006987 Size: 4 KB

New Form 4 - BOSTON SCIENTIFIC CORP Filed: 2025-08-04 AccNo: 0001225208-25-006988 Size: 8 KB

New Form 4 - BOSTON SCIENTIFIC CORP Filed: 2025-08-04 AccNo: 0001225208-25-006985 Size: 21 KB

ANRO Investors Have Opportunity to Lead Alto Neuroscience, Inc. Securities Fraud Lawsuit

New Form 4 - HERON THERAPEUTICS, INC. /DE/ Filed: 2025-08-04 AccNo: 0000950170-25-102161 Size: 7 KB

New Form 4 - HERON THERAPEUTICS, INC. /DE/ Filed: 2025-08-04 AccNo: 0000950170-25-102158 Size: 7 KB

Nuwellis Stockholders Approve All Proposals at Special Meeting

New Form 4 - HERON THERAPEUTICS, INC. /DE/ Filed: 2025-08-04 AccNo: 0000950170-25-102150 Size: 7 KB

New Form 425 - WATERS CORP /DE/ Filed: 2025-08-04 AccNo: 0001193125-25-172712 Size: 96 KB

New Form 4 - REGENXBIO Inc. Filed: 2025-08-04 AccNo: 0001562180-25-005618 Size: 5 KB

New Form DEFA14A - Semler Scientific, Inc. Filed: 2025-08-04 AccNo: 0001104659-25-073710 Size: 382 KB

New Form 8-K - Nuwellis, Inc. Filed: 2025-08-04 AccNo: 0001140361-25-028670 Size: 171 KB Item 5.07: Submission of Matters to a Vote of Security Holders

New Form S-1 - Scilex Holding Co Filed: 2025-08-04 AccNo: 0001193125-25-172703 Size: 21 MB

New Form 8-K - Odyssey Health, Inc. Filed: 2025-08-04 AccNo: 0001683168-25-005638 Size: 597 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 9.01: Financial Statements and Exhibits